Clindamycin Course for Impetigo
For impetigo, oral clindamycin 20 mg/kg/day divided into 3 doses (not to exceed 300-400 mg three times daily in adults) for 7 days is the recommended treatment when topical therapy is insufficient or contraindicated.
Dosing Recommendations
Children
- Oral clindamycin: 20 mg/kg/day divided into 3 doses 1, 2
- Maximum daily dose should not exceed adult dosing
- For children unable to swallow capsules, use clindamycin palmitate oral solution 3
Adults
- 300-400 mg orally three times daily 1, 2
- Take with a full glass of water to avoid esophageal irritation 3
Treatment Duration
7 days is the standard duration for impetigo 4. While the FDA label mentions 10 days for β-hemolytic streptococcal infections 3, recent quality improvement data demonstrates that 7 days of clindamycin for purulent skin infections is optimal and reduces unnecessary antibiotic exposure 4.
When to Use Clindamycin for Impetigo
Clindamycin is appropriate when:
- Topical therapy (mupirocin or retapamulin) has failed or is impractical due to widespread lesions 1, 2, 5
- More than 10 lesions or area >36 cm² 6
- MRSA is suspected or confirmed - clindamycin provides coverage for both S. aureus (including MRSA) and S. pyogenes 7, 8, 2
Important Caveats
Check local clindamycin resistance rates - clindamycin should only be used if local MRSA resistance is low (e.g., <10%) 7, 8. Resistance to clindamycin is increasing in certain geographic areas 9, 10.
Test for inducible clindamycin resistance (D-test) when treating serious infections, though for mild impetigo this may be less critical 8.
Alternative First-Line Options
For localized impetigo (<10 lesions, <36 cm²):
- Mupirocin 2% ointment applied 3 times daily for 5-7 days 7, 1, 2
- Retapamulin ointment applied twice daily 2
For widespread impetigo when oral therapy is needed:
- Cephalexin 25-50 mg/kg/day in 3-4 divided doses (adults: 250 mg four times daily) 1, 2
- Dicloxacillin 25-50 mg/kg/day in 4 divided doses (adults: 250 mg four times daily) 1, 2
These β-lactams are preferred for methicillin-susceptible S. aureus but will miss MRSA 1, 2.
Monitoring
Discontinue clindamycin immediately if significant diarrhea develops - this may indicate Clostridioides difficile infection, which occurs more frequently with clindamycin than other oral antibiotics 7, 3. This risk is higher in elderly patients (>60 years) 3.
No routine laboratory monitoring is required for a 7-day course in otherwise healthy patients.
Clinical Pearls
- Clindamycin provides dual coverage for both S. aureus (including CA-MRSA) and S. pyogenes, making it ideal when the causative organism is uncertain 7, 8
- Avoid tetracyclines (doxycycline) in children <8 years due to tooth discoloration risk 7, 1, 2
- TMP-SMX lacks reliable activity against S. pyogenes and should not be used as monotherapy for impetigo 8
- Rifampin should never be used as monotherapy due to rapid resistance development 7, 8